Reverse Engineering for Generic Oral Solid Dosage Development
Home » About » Reverse Engineering for Generic Oral Solid Dosage Development
Reverse Engineering for Generic Oral Solid Dosage Development
What if you could understand the RLD in a single experiment?
The development of generic oral dosage forms requires an intimate understanding of the formulation strategies and manufacturing techniques used by the innovator. Often times, this knowledge is a difficult black box, requiring significant resources and an array of characterization studies. Using an advanced suite of imaging techniques and structural analysis, the mysteries of the innovator product can be exposed. This information package will examine the techniques and best protocols towards the visualization and quantification to engineer and manufacture an equivalent generic product.
This insider's guide will examine pathways for...
Formulation Strategy Discovery with Reverse Engineering
Process and Manufacturing Optimization
Controlled Release and Complex Dosage Mechanisms
Structural Bioequivalence for Regulatory Review
Internal structural AI analysis of Claritin D12 RLD and CVS Generic